Compared to sporadic AML/MDS cases, variants in ASXL1, SETBP1 and STAG2 are statistically overrepresented in GATA2-deficiency, while variants in DNA methylation modifiers DNMT3A and TET2 seem to be less common (Figure 2B). This evidence concerns the gene GATA2 and myelodysplastic syndrome.